Ticker brief
NVCT
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
31
authors 14d
15
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-07-02 · now +0.30 (−1 bearish … +1 bullish)
Who spoke15
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Omnitrader69 | C | -1.20 | 6 | +0.32 |
| @PurpleDrink_LLC | C | +1.16 | 4 | +0.30 |
| @Brad_E_Schulz | C | · | 4 | +0.28 |
| @Optimalinvestme | C | +0.15 | 3 | +0.30 |
| @semodough | C | -0.75 | 2 | +0.40 |
| @PrismMarketView | C | · | 2 | -0.05 |
| @CEOStockWatcher | C | · | 2 | +0.30 |
| @OzmosiHealth | C | · | 1 | +0.15 |
| @PortfolioArmor | C | +0.66 | 1 | +0.60 |
| @Bezel4455 | C | -2.52 | 1 | +0.55 |
| @BiopharmIQ | B | · | 1 | +0.25 |
| @AlertsAndNews | C | +1.52 | 1 | -0.35 |
| @ClassicRoy | C | +2.01 | 1 | +0.25 |
| @TradeIdeasLLC | C | · | 1 | +0.00 |
| @judahrhodie | C | -0.49 | 1 | +0.30 |
Recent signals30of 31 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @CEOStockWatcher | +0.30 | Reports largest unscheduled insider purchases with dollar amounts and holdings changes. | · | tweet ↗ |
| 2026-07-02 | @CEOStockWatcher | +0.30 | Emerald Hill Ventures bought $900K of Nuvectis Pharma after post-offering dip. | · | tweet ↗ |
| 2026-07-01 | @Brad_E_Schulz | +0.30 | Lists stocks up at least 4% on at least 1.5x average volume. | · | tweet ↗ |
| 2026-07-01 | @judahrhodie | +0.30 | Insider buy alert: CEO and 10% holder Ron Bentsur bought $250K of NVCT. | · | tweet ↗ |
| 2026-07-01 | @Brad_E_Schulz | +0.30 | Intraday stocks up at least 4% on at least 1.5x average volume. | · | tweet ↗ |
| 2026-06-30 | @TradeIdeasLLC | +0.00 | Promotes trade review for NVCT, no standalone stance or setup details. | · | tweet ↗ |
| 2026-06-30 | @ClassicRoy | +0.25 | Reports options volume surge multiples for top momentum names. | · | tweet ↗ |
| 2026-06-30 | @PrismMarketView | -0.45 | Lists mid-day movers with large percentage gains and one decliner. | · | tweet ↗ |
| 2026-06-30 | @Omnitrader69 | +0.20 | Reports NVCT offering at 20 per share after trading sub-10 and says it's fine. | · | tweet ↗ |
| 2026-06-29 | @AlertsAndNews | -0.35 | Nuvectis prices 5M-share public offering at $20 for $100M proceeds. | · | tweet ↗ |
| 2026-06-29 | @semodough | +0.25 | Author views Cantor leading the offering as better sponsorship than prior offerings. | · | tweet ↗ |
| 2026-06-29 | @Omnitrader69 | -0.35 | Reports NVCT offering with Cantor as bookrunner and intended use of proceeds. | · | tweet ↗ |
| 2026-06-28 | @Optimalinvestme | +0.35 | Lists stocks that were strong last week. | · | tweet ↗ |
| 2026-06-27 | @PurpleDrink_LLC | +0.40 | Author notes prior writeups and NVCT tripled in a month. | · | tweet ↗ |
| 2026-06-27 | @BiopharmIQ | +0.25 | Weekly biotech move list with percentage gainers and losers, capped to six tickers. | · | tweet ↗ |
| 2026-06-25 | @Optimalinvestme | +0.25 | Discusses relative strength breakouts and recent high-performing small caps amid weak market. | · | tweet ↗ |
| 2026-06-25 | @Brad_E_Schulz | +0.20 | Sector performance table with gains and ticker lists. | · | tweet ↗ |
| 2026-06-25 | @Brad_E_Schulz | +0.30 | Stocks up at least 4% on >=1.5x average volume for the day. | · | tweet ↗ |
| 2026-06-25 | @Omnitrader69 | +0.45 | Recaps NVCT rising from 18 to 27 after earlier squeeze comment. | · | tweet ↗ |
| 2026-06-24 | @Optimalinvestme | +0.30 | Arabic post says listed stocks gave historic recent gains and are temporarily favorited. | · | tweet ↗ |
| 2026-06-24 | @Omnitrader69 | +0.70 | Says NVCT still looks squeezy and is now 4x from entry. | · | tweet ↗ |
| 2026-06-24 | @Bezel4455 | +0.55 | Bullish oncology momentum watch with pipeline/data interest. | · | tweet ↗ |
| 2026-06-24 | @PrismMarketView | +0.35 | Mid-day movers list with percentage gains/losses for medtech and new energy names. | · | tweet ↗ |
| 2026-06-23 | @PortfolioArmor | +0.60 | Reports October call combo entered in May and sold half today for 3x gain. | · | tweet ↗ |
| 2026-06-23 | @OzmosiHealth | +0.15 | Nuvectis will present Phase 1 oncology results in 3Q26 for NXP-900. | · | tweet ↗ |
| 2026-06-23 | @Omnitrader69 | +0.40 | HC Wainwright raises Nuvectis Pharma target to $39 from $13. | · | tweet ↗ |
| 2026-06-23 | @Omnitrader69 | +0.50 | Reports NVCT swing is now up 3x from entry and may be squeezy. | · | tweet ↗ |
| 2026-06-22 | @PurpleDrink_LLC | +0.35 | Discloses small long-term positions in PGEN, NVCT, and IMRX; no opinion on IOVA. | · | tweet ↗ |
| 2026-06-22 | @PurpleDrink_LLC | +0.25 | Recaps recent trades, NAV ding, trims, and names perking up. | · | tweet ↗ |
| 2026-06-22 | @semodough | +0.55 | NVCT is described as tightly held with high short interest, open-label data coming and breaking out. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.